NCT01852539View on ClinicalTrials.gov

Dexmedetomidine for Laryngeal Mask Airway Insertion

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Drug Usage
Interventions
DRUG

dexmedetomidine

The dose of dexmedetomidine was determined by modified Dixon's up-and-down method, starting from 0.5 μg/kg (0.1 μg/kg as a step size).

DRUG

propofol

Propofol 2.0 mg/kg was administrated

DEVICE

laryngeal mask airway (LMA)

The insertion of laryngeal mask airway (LMA) was attempted, after confirming the loss of eyelash reflex,the bispectral index (BIS) score decreased below 60.

Trial Locations (1)

443-721

Ajou University School of Medicine, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT01852539 - Dexmedetomidine for Laryngeal Mask Airway Insertion | Biotech Hunter | Biotech Hunter